GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO) » Definitions » E10

Vicore Pharma Holding AB (OSTO:VICO) E10 : kr-2.34 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Vicore Pharma Holding AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Vicore Pharma Holding AB's adjusted earnings per share data for the three months ended in Dec. 2024 was kr-0.400. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr-2.34 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-04-05), Vicore Pharma Holding AB's current stock price is kr6.80. Vicore Pharma Holding AB's E10 for the quarter that ended in Dec. 2024 was kr-2.34. Vicore Pharma Holding AB's Shiller PE Ratio of today is .


Vicore Pharma Holding AB E10 Historical Data

The historical data trend for Vicore Pharma Holding AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB E10 Chart

Vicore Pharma Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -2.34

Vicore Pharma Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -1.82 -1.83 -1.83 -2.34

Competitive Comparison of Vicore Pharma Holding AB's E10

For the Biotechnology subindustry, Vicore Pharma Holding AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vicore Pharma Holding AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's Shiller PE Ratio falls into.


;
;

Vicore Pharma Holding AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vicore Pharma Holding AB's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.4/132.9872*132.9872
=-0.400

Current CPI (Dec. 2024) = 132.9872.

Vicore Pharma Holding AB Quarterly Data

per share eps CPI Adj_EPS
201503 -0.119 99.950 -0.158
201506 -0.116 99.995 -0.154
201509 -0.072 100.228 -0.096
201512 -0.095 100.276 -0.126
201603 -0.133 100.751 -0.176
201606 -0.093 101.019 -0.122
201609 -0.085 101.138 -0.112
201612 -0.124 102.022 -0.162
201703 -0.137 102.022 -0.179
201706 -0.128 102.752 -0.166
201709 -0.107 103.279 -0.138
201712 -0.992 103.793 -1.271
201803 -0.010 103.962 -0.013
201806 0.389 104.875 0.493
201809 -0.632 105.679 -0.795
201812 -0.525 105.912 -0.659
201903 -0.389 105.886 -0.489
201906 -0.613 106.742 -0.764
201909 -0.525 107.214 -0.651
201912 -0.584 107.766 -0.721
202003 -0.545 106.563 -0.680
202006 -0.467 107.498 -0.578
202009 -0.632 107.635 -0.781
202012 -0.983 108.296 -1.207
202103 -0.739 108.360 -0.907
202106 -0.954 108.928 -1.165
202109 -1.323 110.338 -1.595
202112 -1.090 112.486 -1.289
202203 -1.265 114.825 -1.465
202206 -0.895 118.384 -1.005
202209 -0.924 122.296 -1.005
202212 -0.798 126.365 -0.840
202303 -0.788 127.042 -0.825
202306 -0.827 129.407 -0.850
202309 -0.580 130.224 -0.592
202312 -0.990 131.912 -0.998
202403 0.272 132.205 0.274
202406 -0.486 132.716 -0.487
202409 -0.540 132.304 -0.543
202412 -0.400 132.987 -0.400

Add all the adjusted EPS together and divide 10 will get our e10.


Vicore Pharma Holding AB  (OSTO:VICO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Vicore Pharma Holding AB E10 Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Vicore Pharma Holding AB Business Description

Traded in Other Exchanges
Address
Kornhamnstorg 53, Stockholm, SWE, 111 27
Vicore Pharma Holding AB is as a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. The company also has an investigational medical device in clinical development namely, Almee which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines